Longevity Health Holdings Receivables

The latest receivables for XAGE is $20K as of June 2026. That compares with $54K in the prior-year period — down 64.1% year over year. Investors often review this figure alongside Longevity Health Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, XAGE's receivables moved from $54K to $20K — a 64.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Longevity Health Holdings's operating scale or balance-sheet position.

A receivables figure of $20K for XAGE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting XAGE's receivables ($20K), review year-over-year change from $54K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.